Article Details
Retrieved on: 2024-05-28 22:16:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
Arbutus Biopharma Corporation (ABUS) announced shareholder approval of significant updates to its 2016 Omnibus Share and Incentive Plan, election of directors, and confirmed Ernst & Young LLP as auditor, reflecting strong corporate governance in biopharma. Tags include relevant aspects: 'Abus, Arbutus Biopharma, Corporate finance, Stock, Arbutus Biopharma Corporation'.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here